Articles By Rob Wright, Chief Editor 2011-2021
-
![First-time CEOs EVR]( "What’s It Like Being A First-Time Biopharma CEO?")
What’s It Like Being A First-Time Biopharma CEO?9/1/2021In this edited transcript of our June 2021 executive virtual roundtable, three first-time CEOs tell us their tales of the good, the bad, and the ugly related to being CEO.
-
![2021_Rob Wright headshot]( "When It’s Time")
When It’s Time8/2/2021When pondering if she wanted to spend the next 10 to 15 years continuing to climb that academic ladder or do something that would be impactful for patients, Laura Niklason, M.D., Ph.D., opted for the latter.
-
![Feature_Humacyte_450x300]( "From Professor To Regenerative Medicine Company CEO")
From Professor To Regenerative Medicine Company CEO8/2/2021Though she cofounded the company in 2004 and played an active role throughout its growth, until November 2020, Laura Niklason, M.D., Ph.D., had never held a c-level title within it.
-
![Going Public_Three headshots_450x300]( "IPO, M&A, And SPAC — 3 Life Science Execs Recount Going Public")
IPO, M&A, And SPAC — 3 Life Science Execs Recount Going Public8/2/2021Taking a company public may not be every entrepreneur’s dream, but it is for many life sciences companies. As 2020 forever changed how IPOs are done, it seems like there is a great opportunity to capture some wisdom from those who have been there, done that.
-
![Mental Wellness iStock-1186418486]( "Mental Wellness — The Next Big Thing")
Mental Wellness — The Next Big Thing7/30/2021Recent events of female athletes expressing the need to focus on their mental health seems to point toward mental wellness being one of the next big things, along with women leaders being willing to "rewrite the rules."
-
![2021_Rob Wright headshot]( "Is Government-Enabled IP Theft Ever A Good Thing?")
Is Government-Enabled IP Theft Ever A Good Thing?7/1/2021I believe waiving IP protections on COVID-19 vaccines (developed by three U.S. companies in record time) will not have any appreciable impact on fixing the global health crisis in the short term.
-
![Feature_Travere_450x300.jpg]( "How A First-Time CEO Transformed Retrophin Into Travere Therapeutics")
How A First-Time CEO Transformed Retrophin Into Travere Therapeutics7/1/2021Eric Dube, Ph.D., was dubious when an executive recruiter pitched him the CEO position at previously embattled Retrophin (remember Martin Shkreli?). But he took the job in January 2019 and now has guided the $1.5 billion biopharma as it has increased sales, implemented a new diverse and inclusive culture, advanced its pipeline, and adopted a new name (Travere).
-
![Feature - Vaxxinity - Mei Mei_450x300]( "Building A COVID-19 Vaccine Company In A Few Months")
Building A COVID-19 Vaccine Company In A Few Months6/1/2021Mei Mei Hu, J.D., and her husband Lou Reese know what it’s like to develop a drug during a pandemic. Nearly 20 years ago they helped develop a vaccine and antibody test for the SARS outbreak. But now they were considering starting a COVID-19 vaccine company — during 2020.
-
![2021_Rob Wright headshot]( "Be The Inspiration")
Be The Inspiration6/1/2021The world is hurting. Now more than ever, people need and want to be inspired by people. Just imagine what we can accomplish if we all strive to be the inspiration we seek.
Rob Wright
Rob Wright was chief editor of Life Science Leader magazine from 2011-2021. Prior to joining the publication, he spent nearly 20 years in the pharmaceutical industry. During his industry career, Wright conducted well over 1,000 presentations and roundtable discussions, including the facilitation of FDA-mandated clinical training programs for hundreds of licensed healthcare providers. He has chaired, moderated, and served as a speaker at industry and academic conferences, and served as co-chair for the 2015 and 2018 BIO International conference’s educational planning committee. Wright’s 500+ published articles have appeared in peer-reviewed academic journals, B2B magazines and online publications. He received a B.S. in Business Administration from Indiana University of Pennsylvania, MBA with distinction from Gannon University, and completed his doctoral coursework in marketing at Cleveland State University. He is a member of international business honor societies Sigma Beta Delta and Beta Gamma Sigma. He can be followed on Twitter @RfwrightLSL